News
The July 2026 Committee Vote
Seven peptides went to an FDA advisory committee on 23 and 24 July 2026. Six came out with a yes. Not one vote was close to unanimous, and that is the part almost every write-up got wrong.
What changed, and what it actually means.
Seven peptides went to an FDA advisory committee on 23 and 24 July 2026. Six came out with a yes. Not one vote was close to unanimous, and that is the part almost every write-up got wrong.
Six peptides got a yes. The widest margin all meeting was three votes. Here is what that actually tells you.
The 2026 vote was a vote to undo something. This is the something, and what it changed about who stands between a buyer and a jar.
The panel voted. That was one step of four. Here is the rest, what can stall at each one, and why nobody can honestly give you a date.
Seven peptides went to the committee. Emideltide — the compound most people know as DSIP — came out with a no, by a single vote.